[1]
“Analytical techniques for Reverse Engineering of Reference products for the development of generic Oral Solid Dosage Forms”, Int. J. Pharm. Sci. Drug Res., vol. 17, no. 1, pp. 74–82, Jan. 2025, doi: 10.25004/IJPSDR.2025.170111.